Detalles de la búsqueda
1.
Biomarkers of immunotherapy for non-small cell lung cancer.
Jpn J Clin Oncol
; 54(1): 13-22, 2024 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37823218
2.
Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.
Br J Cancer
; 129(12): 2003-2013, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37731022
3.
Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma.
Pathol Int
; 73(5): 188-197, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36896472
4.
Performance of Japanese patients in registrational studies.
Jpn J Clin Oncol
; 52(1): 53-64, 2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34978326
5.
Prognostic impact of peripheral blood neutrophil to lymphocyte ratio in advanced-stage pulmonary large cell neuroendocrine carcinoma and its association with the immune-related tumour microenvironment.
Br J Cancer
; 124(5): 925-932, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33250511
6.
Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
BMC Cancer
; 19(1): 163, 2019 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30808322
7.
Correction: Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer.
Br J Cancer
; 129(12): 2034, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37923915
8.
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
Oncology
; 94(4): 207-214, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29393275
9.
Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer.
Oncology
; 91(1): 41-7, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27234033
10.
Clinical significance of inter-assay discrepancy in PD-L1 evaluation for the efficacy of pembrolizumab in advanced NSCLC with high PD-L1 expression.
Lung Cancer
; 191: 107788, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593478
11.
Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy.
Lung Cancer
; 179: 107183, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37037178
12.
Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma.
Nat Commun
; 14(1): 8375, 2023 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38102134
13.
Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients.
Clin Lung Cancer
; 23(6): 477-486, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644780
14.
Safety Implications of Switching Pembrolizumab Dosage From 200 mg Every 3 Weeks to 400 mg Every 6 Weeks in Patients With Advanced NSCLC.
J Thorac Oncol
; 17(10): 1227-1232, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35788404
15.
Nivolumab versus pembrolizumab in previously-treated advanced non-small cell lung cancer patients: A propensity-matched real-world analysis.
Lung Cancer
; 167: 49-57, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35397298
16.
Baseline PD-L1 expression and tumour-infiltrated lymphocyte status predict the efficacy of durvalumab consolidation therapy after chemoradiotherapy in unresectable locally advanced patients with non-small-cell lung cancer.
Eur J Cancer
; 162: 1-10, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34936940
17.
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.
Cancer Cell
; 40(2): 201-218.e9, 2022 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090594
18.
Smoking History Predicts High Presence of TILs and Efficacy of PD-1 Blockade in PD-L1 Expression-negative Non-small Cell Lung Cancer Patients.
Anticancer Res
; 41(11): 5739-5747, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34732447
19.
Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions.
Sci Rep
; 11(1): 18762, 2021 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34548567
20.
Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC.
J Thorac Oncol
; 16(12): 2078-2090, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34419685